Silver staining of nucleolar organizer regions

Journal of Histotechnology

Volumn 19, Issue 3, 1996, Pages 241-256

  Jewell, Scott D ^a   Cordial, Carolyn R ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

AgNOR; image analysis; malignancy; nucleolar organizer regions; prognosis

Indexed keywords

BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER; CELL PROLIFERATION; CHROMOSOME NOR; DIFFERENTIAL DIAGNOSIS; GYNECOLOGIC CANCER; HUMAN; IMAGE ANALYSIS; LUNG CANCER; LYMPHOMA; MELANOMA; NONHODGKIN LYMPHOMA; PROSTATE CANCER; REVIEW; SILVER STAINING; TISSUE FIXATION;

EID: 0029744691     PISSN: 01478885     EISSN: None     Source Type: Journal    
DOI: 10.1179/his.1996.19.3.241     Document Type: Review

References (124)

1. Medline CDROM database search under keytext "AgNOR", as of October 31, 1995
2. Alberts B, Bray D, Lewis J et al: Molecular Biology of the Cell, 3rd ed. Garland Publishing, Inc, 1994, pp 378-382
3. Derenzini M, Sirri V, Pession A et al: Quantitative changes of the two major AgNOR proteins, nucleolin and protein B23, related to stimulation of rDNA transcription. Exper Cell Res 219:276-282, 1995
4. Roussel P, Hernandez-Verdun D: Identification of Ag-NOR proteins, markers of proliferation related to ribosomal gene activity. Exper Cell Res 214:465-472, 1994
5. Derenzini M, Trere D: AgNOR proteins as a parameter of the rapidity of cell proliferation. Zentralblatt fur Pathologie 140: 7-10, 1994
6. Freidman R, Grin C, Heilman E et al: Distinguishing benign and malignant melanocytic lesions with the AgNOR method. Dermatol Clinics 9:689-693, 1991
7. Carbajo S, Orfao A, Vicente-Villardon V, Carbajo-Perez E: Expression of silver-stained nucleolar organizer regions is coupled to cell cycle in rat thymic cells. Cytometry 14:46-52, 1993
8. Sirri V, Roussel P, Trere D et al: Amount variability of total and individual Ag-NOR proteins in cells stimulated to proliferate. J Histol Cytol 43:887-893, 1995
9. Rowlands D, Ayers J, Crocker J: The effect of different fixatives and length of fixation time on subsequent AgNOR staining for frozen and paraffin-embedded tissue sections. Histochem 25:123-132, 1993
10. Hernandez-Verdun D, Hubert J, Bourgeois CA, Bouteille M: Ultrastructural localization of Ag-NOR stained proteins in the nucleolus during the cell cycle and in other nucleolar structures. Chromosoma 79:349-362, 1980
11. Ploton D, Menager M, Jeannesson P et al: Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem J 18:5-14, 1986
12. Öfner D, Bankfalvi A, Riehemann K et al: Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues. Mod Pathol 7:946-950, 1994
13. Lomholt B, Toft J: The effect of pH on silver staining of nucleolus organizer regions. Stain Technol 62:101-105, 1987
14. Derenzini M, Nardi F, Farabegoli F et al: Distribution of silver-stained interphase nucleolar organizer regions as a parameter to distinguish neoplastic from nonneoplastic reactive cells in human effusions. Acta Cytolog 33:491-498, 1989
15. Crocker J: The trials and tribulations of interphase AgNORs. J Patholo 175:367-368, 1995
16. Rüschoff J, Plate K, Bittinger A, Thaomas C: Nucleolar organizer regions (NORs): basic concepts and practical application in tumor pathology. Path Res Pract 185:878-885, 1989
17. Pich A, Chiusa L, Margaria E: Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis. Cancer Detect Prevent 19:282-291, 1995
18. Crocker J, Boldly D, Egan M: How should we count AgNORs? Proposals for a standardized approach. J Pathol 158:185-188, 1989
19. Derenzini M, Ploton D: Interphase nucleolar organizer regions in cancer cells. In International Review of Experimental Pathology. Molecular Cell Pathology, Richter GW, Solez K (ed). Academic Press, San Diego, CA 1991, pp 149-192
20. Hufnagl P, Guski H, Schulz HJ: Measuring of AgNORs using image analysis. Zentralbl Pathol 140, 31-35, 1994
21. Crocker J: Nucleolar organizer regions. In Current Topics in Pathology, Underwood JE (ed). Springer, Heidelberg, 1988
22. Oberholzer M: Morphometrics in Clinical Pathology. Allgemeine Grundlagen. Springer Verlag, Berlin, 1983
23. Imamura Y, Noriki S, Tsuzuki H et al: Fluorescent staining of nucleolar organizer regions for three-dimensional display by confocal laser scanning microscope. Eur J Histochem 37:321-328, 1993
24. Korkolopoulou P, Christodoulou P, Papanikolaou A, Thomas-Tsagli E: Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. Am J Surg Pathol 17:912-919, 1993
25. Ducrot P, Joundi A, Diebold M, Pluout M: Value of the nucleolar organizers (AgNORs) in brain gliomas. Arch Anat Cytol Pathol 39:88-93, 1991
26. Kara A, Sakai N, Yamada H et al: Nucleolar organizer regions in vascular and neoplastic cells of human gliomas. Neurosurgery 29:211-215, 1991
27. Hara A, Sakai N, Yamada H et al: Rapid detection of proliferating potential in human brain tumors by nucleolar organizer region staining on squash preparations. J Cancer Res Clin Oncol 117:510-514, 1991
28. Hara A, Hirayama H, Sakai N et al: Nucleolar organizer region score and Ki-67 labeling index in high-grade gliomas and metastatic brain tumours Acta Neurochir (Wien) 109: 37-41, 1991
29. Li Q, Ding H: Quantitative study on DNA content and nucleolar organiser regions in astrocytoma. China Hua Ping Li Hsueh Tsa Chili 20:201-204, 1991
30. Martin H, Beil M, Hufnagl P et al: Computer assisted image analysis of nucleolar organizer regions (NORs): a pilot study of astrocytomas and glioblastomas. Acta Histochem 90:189-196, 1991
31. Plate K, Rüschoff J, Mennel H: Cell proliferation in intracranial tumours: selective silver staining of nucleolar organizer regions (AgNORs). Application to surgical and experimental neuro-oncology. Neuropathol Appl Neurobiol 17: 121-132, 1991
32. Kajiwara K, Nishizaki T, Orita T et al: Silver colloid staining technique for analysis of glioma malignancy. J Neurosurg 73:113-117, 1990
33. Plate K, Arndt D, Hellwig D et al: Assessment of histogenesis and proliferative potential in cytologic specimens of human brain tumors: Value of Immunocytochemistry and nucleolar organizer regions. Analy Quant Cytol Histol 12: 157-164, 1990
34. Boon A, Sharif H: Value of AgNOR method in predicting recurrence of meningioma. J Clin Pathol 42:1002-1003, 1989
35. Orita T, Kajiwara K, Nishizaki T et al: Nucleolar organizer regions in meningioma. Neurosurgery 26:43-46, 1990
36. Scarpelli M, Montironi R, Sisti S et al: Quantitative evaluation of recurrent meningiomas. Pathol Res Pract 185:746-751, 1989
37. Maier H, Morimura T, Öfner D et al: Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: Relations with grade or malignancy and proliferation indices. Acta Neuropathol 80:156-162, 1990
38. Plate K, Rüschoff J, Mennel H: Nucleolar organizer regions in meningiomas: Correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome. Analy Quant Cytol Histol 12:429-438, 1990
39. Centeno BA, Louis D, Kupsky W et al: The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens. Anatom Pathol 100:690-696, 1993
40. Manuelidis L: Active nucleolus organizers are precisely positioned in adult central nervous system cells but not in neuroectodermal tumor cells. J Neuropathol Exp Neurol 43: 225-241, 1984
41. Louis D, Meehan S, Ferrante R et al: Use of the silver nucleolar organizer region (AgNOR) technique in the differential diagnosis of central nervous system neoplasia. J Neuropathol Exp Neurol 51:150-157, 1992
42. Bocking A, Chatelain R, Biesterfeld S et al: DNA grading of malignancy in breast cancer: Prognostic validity, reproducibility, and comparison with other classifications. Anal Quant Cytol Histol (11)2:73-80, 1989
43. Bloom H, Field J: Impact of tumor grade and host resistance on survival of women with breast cancer. Cancer 28:1580-1589, 1971
44. Numura Y, Miura S, Koyama H et al: Relative effects of steroid hormone receptors on the prognosis of patients with operable breast cancer. Cancer 69:153-164, 1992
45. Auer G, Caspersson T, Wallgren A: DNA content and survival in mammary carcinoma. Analy Quant Cytol Histol 3: 161-165, 1980
46. Fallenius A, Auer G, Carstensen J: Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer 62:521-530, 1988
47. Auhele M, Auer G, Gais P et al: Nucleolus organizer regions (AgNORs) in ductal mammary carcinoma. Pathol Res Pract 190, 129-137, 1994
48. Mourad W, Setrakian S, Hales M et al: The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. Cancer (74)6:1739-1745, 1994
49. Pich A, Margaria E, Chiusa L: Proliferative activity is a significant prognostic factor in male breast carcinoma. Am J Pathol 145.481-489, 1994
50. Charpin C, Bonnier P, Piana L et al: Correlation of nucleolar organizer regions and nuclear morphometry assessed by automatic image analysis in breast cancer with aneuploidy, Ki67 immunostainmg, histopathologic grade and lymph node involvement. Path Res Pract 188:1009-1017, 1992
51. Bockmuhl U, Theissig F, Dimmer V, Kunze K: The impact of nucleolar organizer regions for the lymph node spread and prognosis of invasive ductal mammary carcinoma. Path Res Pract 187:437-443, 1991
52. Tokkanen S, Joensuu H: AgNOR counts have no prognostic value in breast cancer. J Pathol 169:251-254, 1993
53. Sacks N, Robertson J, Ellis I et al: Silver-staining nucleolar organizer region counts are of no prognostic value in primary breast cancer. Eur J Surg Onc 18:98-102, 1992
54. Eskelinen M, Lipponen P, Collan Y, Syrjanen K: The role of nucleolar organizer regions as prognostic factors in breast cancer. Eur J Cancer 27:989-992, 1991
55. Aaltomaa S, Lipponen P, Papinaho S, Syrjanen K: Proliferating cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer. J Cancer Res Clin Oncol 119:288-294, 1993
56. Delahunt B, Bethwaite P, Nacey J: Renal cell carcinoma in New Zealand, a national survival study. Urology 43:300-309, 1994
57. Delahunt B, Nacey J: Renal cell carcinoma: histological indicators of prognosis. Pathology 19:258-263, 1987
58. Delahunt B, Bethwaite P, Thornton A, Ribas J: Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Cancer 75:2714-2719, 1995
59. Delahunt B, Ribas J, Nacey J, Bethwaite P: Nucleolar organizer regions and prognosis in renal carcinoma. J Pathol 163:31-37, 1991
60. Delahunt B, Bethwaite P, Nacey J, Ribas J: Variation in AgNOR scores for renal cell carcinoma. J Pathol 168:424-425, 1992
61. Delahunt B, Bethwaite P, Nacey J, Ribas J: Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: Comparison with tumor grade, mitotic index, and silver staining nucleolar organizer region numbers. J Pathol 170:471-477, 1993
62. Lipponen P, Eskelinen M: Volume corrected mitotic index (M/V index) and mitotic index activity (MAI) in transitional cell bladder cancer. Eur Urol 18:258-262, 1990
63. Lipponen P, Eskelinen M, Sotarrauta M: Prediction of superficial bladder cancer by histoquantitative methods. Eur J Cancer 26:1060-1063, 1990
64. Lipponen P, Eskelinen M, Kiviranta J, Nordling S: Classic prognostic factors, flow cytometry data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer. Anticancer Res 11:911-916, 1990
65. Lipponen P, Eskelinen M, Kiviranta J, Pesonen E: Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction. Eur Urol 146:1535-1540, 1991
66. Lipponen P, Eskelinen M, Nordling S: Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S phase fraction and DNA ploidy. Eur J Cancer 27:877-881, 1991
67. Lipponen P, Eskelinen M, Nordling S: Nucleolar organizer regions as prognostic factors in transitional cell bladder cancer. Br J Cancer 64:1139-1144, 1991
68. Lipponen P, Eskelinen M: Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value. Br J Cancer 66:171-176, 1992
69. Martin H, Hugnagl P, Beil M et al: Nucleolar organizer region-associated proteins in cancer cells. Anal Quant Cytology and Histology 14:312-319, 1991
70. Rüschoff J, Zimmermann R, Ulshofer B, Thomas C: Silver-stained nucleolar organizer proteins in urothelial bladder lesions. Path Res Pract 188:593-598, 1992
71. Coumbe A, Mills B, Brown C: Nucleolar organizer regions in endometrial hyperplasia and neoplasia. Pathol Res Pract 186:254-259, 1990
72. Papadimitiou C, Athanasiadou S, Stylianidou A, Karameris A: Nucleolar organizer regions in the normal, hyperplastic and carcinomatous epithelium of endometrium. Virchows Archiv B Cell Pathol 60:155-160, 1991
73. Chalas E, Chumas J, Barbieri R, Mann W: Nucleolar organizer regions in endometriosis, atypical endomelriosis and clear cell and endometrioid carcinomas. Gynecol Oncol 40: 260-263, 1991
74. Miller B, Morris M, Silva E: Nucleolar organizer regions: A potential prognostic factor in adenocarcinoma of the endometrium. Gynecol Oncol 54:137-141, 1994
75. Wilkinson N, Buckley H, Chawder L, Fox H: Nucleolar organizer regions in normal, hyperplastic and neoplastic endometria. J Gynecol Pathol 9:55-59, 1990
76. Nielsen A, Nyholm H, Engel P: Expression of MIB-1 (Paraffin Ki-67) and AgNOR morphology of endometrial adenocarcinomas of endometrioid type. Intl J Gynecol Pathol 13: 37-44, 1994
77. Lahshmi S, Nair S, Jayasree K et al: Argyrophilic nucleolar organizer regions (AgNORs) in inflammatory pre-malignant and malignant lesions of the uterine cervix. Cancer Letters 51:197-201, 1993
78. Leopardi O, Colavecchio A, Colecchia M et al: Value of AgNOR counts in cervical pathology. Eur J Gynecol Oncol 6:539-544, 1992
79. Egan M, Freeth M, Crocker J: The relationship between cervical intraepithelial neoplasia and the size and numbers of nucleolar organiser regions. Gynecol Oncol 36:30-34, 1990
80. Egan M, Crocker J: Nucleolar organiser regions in pathology. Br J Cancer 65:1-7, 1992
81. Bibbo N, Dytch H, Alenghat E et al: DNA ploidy profiles as prognostic indicators in CIN lesions. Am J Clin Pathol 92: 261-265, 1989
82. Crum C: Identifying high risk precursors of cervical cancer. Am J Clin Pathol 92:379-382, 1989
83. Crocker J, Nar P: Nucleolar organizer regions in lymphomas. J Pathol 151:111, 1987
84. Jakic-Razumovic J, Petrovecki M, Dominis M: AgNOR predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification. Mod Pathol 8:143-149, 1995
85. Munakata S, Hendricks J: Morphometric analysis of AgNORs in imprints and sections from non-Hodgkin's lymphomas. Anal Quan Cyto Hist 15:329-334, 1993
86. Korkolopoulou P, Patsouris E, Pangalis G et al: A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas. Human Pathol 24:371-377, 1993
87. Trere D, Pession A, Basso G et al: Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia. Br J Cancer 70: 1198-1202, 1994
88. Matsuura H, Kuwano H, Morita M et al: Predicting recurrence time of esophageal carcinoma through assessment of histologic factors and DNA ploidy. Cancer 67:1406-1411, 1991
89. Morita M, Kuwano H, Matsuda H et al: Prognostic significance of argyrophilic nucleolar regions in esophageal carcinoma. Cancer Res 51:5339-5341, 1991
90. Suresh U, Chawner L, Buckley H, Fox H: Do ANOR counts reflect cellular ploidy or cellular proliferation? A study of trophoblastic tissue. J Pathol 160:213-215, 1990
91. Kobayashi I, Matsuo K, Ozeki S et al: The proliferative activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nuclear organizer region staining. Hum Pathol 26:907-913, 1995
92. Rajendrua R, Nair S: Silver-binding nucleolar organizer region proteins as a possible prognostic indicator in oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 74:481-486, 1992
93. Ahiskali R, Alican Y, Ekicioglu G et al: Evaluation of three different AgNOR counting methods in advanced carcinoma of the prostate. Prostate 26:105-110, 1995
94. Eskelinen M, Lipponen P, Syrjanen K: Nucleolar organizer regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma. Anticancer Res 12;1635-1640, 1992
95. Masai M, Abe K, Akimoto S et al: Argyrophilic nucleolar organizer regions in benign hyperplastic and cancerous human prostates. Prostate 20:1-13, 1992
96. Ghazizadeh M, Sasaki Y, Oguro T, Aihara K: Silver staining of nucleolar organizer regions in prostatic lesions. Histopathology 19:369-372, 1991
97. Sakr W, Sarkar F, Sreepathi P et al: Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF. Prostate 22:147-154, 1993
98. Goodpasture C, Bloom S: Visualization of nucleolar organizer regions in mammalian chromosomes using silver staining. Chromosoma 53:37-50, 1975
99. Trster H, Spring H, Meissner B et al: Structural organization of an active, chromosomal nucleolar organizer region (NOR) identified by light microscopy, and subsequent TEM and STEM electron microscopy. Chromosoma 91:151-163, 1985
100. Olson M, Thompson B: Distribution of proteins among chromatin components of nucleoli. Biochemistry 22:3187-3193, 1983
101. Buys C, Osinga J: Abundance of protein-bound sulphydryl and disulfide groups at chromosomal nucleolus organizing regions. A cytochemical study on the selective silver staining of NORs. Chromosoma 77:1-11, 1980
102. Janmohamed R, Murray P, Crocker J, Leyland MJ: Sequential demonstration of nucleolar organizer regions and Ki-67 immunolabelling in non-Hodgkins lymphoma. Clin Lab Haematol 12:395-399, 1990
103. Crocker J, Skilbeck N: Nucleolar organizer region associated proteins in cutaneous melanotic lesions: A quantitative study. J Clin Pathol 40:885-889, 1987
104. Sementa A, Gambini C, Borgiani L et al: Le regioni organizzatrici del nucleolo nelle lesioni melanocritarie benigne e maligne: studio quantitativo. Pathologica 31:231-237, 1989
105. Reis J, Tellechea O, Poiares Baptista A: Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions. Dermatologica 183:136-138, 1991
106. Evans A, Orrell J, Grant A: Re-evaluating nucleolar organiser regions in difficult cutaneous melanocytic lesions: a study with quantitation and pattern analysis. J Pathol 165: 61-67, 1991
107. Leong A, Gilham P: Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi. Hum Pathol 20:257-262. 1989
108. Pich A, Aloi F, Margaria F, Tomasini C: Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus. Dermatologica 183:246-250, 1991
109. Fogt F, Vortmeyer A, Tahan S: Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions. Am J Dermatopathol 17(1):12-17, 1995
110. Gonzalez-Campora R, Armas-Padron J, Rios-Martin J et al: Nucleolar organizer regions in pigmented skin lesions: value in the differential diagnosis of Spitz nevi. Anal Quant Cytol Histol 13:16-22, 1991
111. Fallowfield M, Dodson A, Cook M: Nucleolar organizer regions in melanocytic dysplasia and melanoma. Histopathology 13:95-99, 1988
112. Fallowfield M, Cook M: The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions. Histopathology 14:299, 1989
113. Di-Gregorio C, Losi L, Annessi G et al: Nucleolar organizer regions in malignant melanoma and melanocytic nevi: comparison of two counting methods. Am J Dermatopathol 13: 329-333, 1991
114. Friedman R, Grin C, Heilman E et al: Distinguishing benign and malignant melanocytic lesions with the AgNOR method. Dermatol Clin 9(4):689-693, 1991
115. Rebora A: Prognosing melanomas: The argyrophilic nucleolar organizer region approach. Dermatology 185:166-168, 1992
116. Denham P, Salisbury J: Nucleolar organiser region-associated proteins in cutaneous melanotic lesions: a quantitative study. J Pathol 154:64A-65A, 1988
117. Howat A, Wnght A, Cotton D et al: AgNORs in benign, dysplastic, and malignant melanocytic skin lesions. Am J Dermatopathol 12:156-161, 1990
118. Gambini C, Casazza S, Borgiani L et al: Counting the nucleolar organizer region-associated proteins is a prognostic clue of malignant melanoma. Arch Dermatol 1993
119. Howat A, Giri D, cotton D, Slater D: Nucleolar organizer regions in spitz nevi and malignant melanoma. Cancer 63: 474-478, 1989
120. Gambini C, Casazza S, Borgiani L et al: Counting the nucleolar organizer region-associated proteins is a prognostic clue of malignant melanoma. Arch Dermatol 128:487-490, 1992
121. Ronan SG, Han MS, Das Gupta TK: Histologic prognostic indicators in cutaneous malignant melanoma. Semin Oncol 15(6):558-65, 1988
122. De Rosa G, Saibano S, Barra E et al: Nucleolar organizer regions in aggressive and nonaggressive basal cell carcinoma of the skin. Cancer 69:123-6, 1992
123. Gonzalez A, Kumar D, Sanchez R: AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting. Am J Dermatopathol 16(4):372-376, 1994
124. Fissler-Eckhoff A, Becker T, Sudhoff H, Muller K: AgNOR counts in preneoplastic lesions of the bronchus. Path Res Pract 190:389-393, 1994